Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell S Cairo

Showing results (141-150 of 268) with videos related to

Pageof 27
Sort By:
Oncotarget|January 5, 2018
High-dose sitagliptin for systemic inhibition of dipeptidylpeptidase-4 to enhance engraftment of single cord umbilical cord blood transplantationSherif S Farag, Robert Nelson, Mitchell S Cairo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2025
Inflammatory Modulation by Cord Blood Stem Cells Prevented Digit Deformation in Recessive Dystrophic Epidermolysis BullosaMorgan Anderson-Crannage, Alexander Nyström, Rahim Hirani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2010
Autologous peripheral blood stem cell transplantation in children with refractory or relapsed lymphoma: results of Children's Oncology Group study A5962Richard E Harris, Amanda M Termuhlen, Lynette M Smith, et al.
British Journal of Haematology|December 21, 2004
Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological studyMitchell S Cairo, Virginia Davenport, Olga Bessmertny, et al.
Journal of Pediatric Hematology/Oncology|September 29, 2006
Mature B-cell lymphoma in children and adolescents: International group pathologist consensus correlates with histology technical qualityMark A Lones, Martine Raphael, Sherrie L Perkins, et al.
Journal for Immunotherapy of Cancer|May 18, 2022
Risk-adapted chemoimmunotherapy using brentuximab vedotin and rituximab in children, adolescents, and young adults with newly diagnosed Hodgkin's lymphoma: a phase II, non-randomized controlled trialJessica Hochberg, Jaclyn Basso, Qiuhu Shi, et al.
Stem Cells Translational Medicine|September 29, 2023
Early Postnatal Expression of Tgfβ-1 and Fgf-2 Correlates With Regenerative Functions of Unrestricted Somatic Stem Cell Infusion After Rabbit GMH-IVHDina A Finkel, Ana Malfa, Yanling Liao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2020
Exposed CendR Domain in Homing Peptide Yields Skin-Targeted Therapeutic in Epidermolysis BullosaToini Pemmari, Larisa Ivanova, Ulrike May, et al.
Seminars in Hematology|December 1, 2020
Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activityMeisam Naeimi Kararoudi, Brian P Tullius, Nitin Chakravarti, et al.
British Journal of Haematology|July 31, 2007
Immunophenotypic identification of possible therapeutic targets in paediatric non-Hodgkin lymphomas: a children's oncology group reportRodney R Miles, Mitchell S Cairo, Prakash Satwani, et al.
Pageof 27

Showing results (141-150 of 268) with videos related to

Sort By:
Pageof 27
Oncotarget|January 5, 2018
High-dose sitagliptin for systemic inhibition of dipeptidylpeptidase-4 to enhance engraftment of single cord umbilical cord blood transplantationSherif S Farag, Robert Nelson, Mitchell S Cairo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2025
Inflammatory Modulation by Cord Blood Stem Cells Prevented Digit Deformation in Recessive Dystrophic Epidermolysis BullosaMorgan Anderson-Crannage, Alexander Nyström, Rahim Hirani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2010
Autologous peripheral blood stem cell transplantation in children with refractory or relapsed lymphoma: results of Children's Oncology Group study A5962Richard E Harris, Amanda M Termuhlen, Lynette M Smith, et al.
British Journal of Haematology|December 21, 2004
Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological studyMitchell S Cairo, Virginia Davenport, Olga Bessmertny, et al.
Journal of Pediatric Hematology/Oncology|September 29, 2006
Mature B-cell lymphoma in children and adolescents: International group pathologist consensus correlates with histology technical qualityMark A Lones, Martine Raphael, Sherrie L Perkins, et al.
Journal for Immunotherapy of Cancer|May 18, 2022
Risk-adapted chemoimmunotherapy using brentuximab vedotin and rituximab in children, adolescents, and young adults with newly diagnosed Hodgkin's lymphoma: a phase II, non-randomized controlled trialJessica Hochberg, Jaclyn Basso, Qiuhu Shi, et al.
Stem Cells Translational Medicine|September 29, 2023
Early Postnatal Expression of Tgfβ-1 and Fgf-2 Correlates With Regenerative Functions of Unrestricted Somatic Stem Cell Infusion After Rabbit GMH-IVHDina A Finkel, Ana Malfa, Yanling Liao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2020
Exposed CendR Domain in Homing Peptide Yields Skin-Targeted Therapeutic in Epidermolysis BullosaToini Pemmari, Larisa Ivanova, Ulrike May, et al.
Seminars in Hematology|December 1, 2020
Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activityMeisam Naeimi Kararoudi, Brian P Tullius, Nitin Chakravarti, et al.
British Journal of Haematology|July 31, 2007
Immunophenotypic identification of possible therapeutic targets in paediatric non-Hodgkin lymphomas: a children's oncology group reportRodney R Miles, Mitchell S Cairo, Prakash Satwani, et al.
Pageof 27